Next-gen medical imaging facility to advance future of healthcare
Sydney Imaging's Hybrid Theatre.
Providing cutting-edge and with technical expertise, a new research and training hub at the University of Sydney 鈥� 鈥� will assist researchers to tackle frontier questions in healthcare and medical research. Imaging technology allows researchers to study complex biological systems and disease processes non-invasively, and gain insights into scientific and medical problems not available by other means.
Sydney Imaging鈥檚 flagship at the combines a range of biomedical imaging technologies, artificial intelligence, robotics and pioneering surgical practice and training. Image-guided and robotic surgery are used to develop and perfect the complex surgical procedures of tomorrow, resulting in less invasive techniques and better outcomes.
The Hybrid Theatre showcases Australia鈥檚 first , one of the most advanced robotic imaging systems currently available. Manufactured by , it delivers high quality and CT-like 3D images quickly using less radiation 鈥� and accommodates any patient regardless of their size, condition or position.
The theatre also features in-room cameras and videoconferencing to record and stream live procedures for research and teaching purposes.
Inside Sydney Imaging's Hybrid Theatre
Watch video
Investing in the future of healthcare
Speaking at the launch of Sydney Imaging, at the Charles Perkins Centre this morning, NSW Secretary of Health Elizabeth Koff said Sydney Imaging was an investment in our future health.
Sydney Imaging is one of Australia鈥檚 most sophisticated biomedical imaging facilities reserved for research and education 鈥� a rarity in the world. It is a boon for the NSW and Australian health research community, and for our broader society which will ultimately benefit from discoveries made there.
University of Sydney Vice-Chancellor and Principal Dr Michael Spence said the facility forms part of the University鈥檚 program to invest in world-class research infrastructure that attracts the best and brightest.
鈥�Sydney Imaging empowers our finest researchers from across a range of disciplines, and our partners, to find innovative solutions for the world鈥檚 most complex health conditions,鈥� he said. 鈥淚ts Hybrid Theatre, representing the future of technologically-advanced operating theatres, will enable the high-level training and experience our next generation of researchers and healthcare workers will need to carry this work forward.鈥�
Enabling healthcare discoveries and treatments
Plans to further enhance Sydney Imaging鈥檚 capabilities will result in significant research breakthroughs, Academic Director of Core Research Facilities predicted.
鈥淥ne of the largest surgical theatres in the country, the Hybrid Theatre includes an adjacent space that will soon house a clinical MRI scanner,鈥� he said. 鈥淩esearchers will be able to easily combine magnetic resonance imaging with X-ray and ultrasound systems, greatly increasing the range of procedures they can undertake. We are also exploring how surgical robotics might interact this technology, and are working with experts at the University鈥檚 to develop new applications in surgery and medicine.鈥�
Deputy Director of the Hybrid Theatre, , explained the term 鈥榟ybrid鈥� represented a new way of performing surgeries 鈥� a hybrid of traditional open surgeries and the more minimally invasive procedures the theatre supported.
鈥淭he Hybrid Theatre also represents a hybrid between the massive technological and academic strengths of the University, and the drive for innovative and effective treatments from the hospitals we partner with,鈥� he added.聽
Just imagine what we will be able to achieve by exploiting this site鈥檚 capacity to integrate the highest resolution imaging with current robotic capabilities, as well as development and nanoscale robotics.
The ARTIS pheno C-Arm, manufactured by Siemens Healthineers.
Partnerships key to success
Based at the University of Sydney鈥檚 and , close to the Marie Bashir Institute and Royal Prince Alfred Hospital, Sydney Imaging acts as a hub for the University鈥檚 faculties and affiliated research institutes, and is intended to bolster the University鈥檚 work with local health partners including .
Patients will be the ultimate beneficiary of the strategic location and collaboration, explained Executive Director of , Professor Garry Jennings.
鈥淭his initiative offers a valuable opportunity for the local health community to strengthen connections with existing collaborators and foster new partnerships 鈥� in order to advance scientific and medical discoveries and ensure our healthcare system remains fit for future purpose,鈥� he said.
The acquisition of an ARTIS pheno C-Arm was described as globally significant by Michael Shaw, Managing Director of manufacturer Siemens Healthineers ANZ.
鈥淲e are excited to partner with Sydney Imaging to bring this revolutionary hybrid robotic imaging system 鈥� that combines images, robotics and surgical techniques with precision 鈥� to Australia,鈥� he said. 鈥淚t opens the door for Australia鈥檚 surgical and medical research elite to explore an unprecedented world of capabilities in therapy, interventional radiology and surgery.鈥�
A will follow the official launch of Sydney Imaging, featuring a series of research lectures by local and international leaders from the clinical, preclinical and surgical research imaging communities.
